Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Novel use proposed for EGCg: inhibition of HIV-1

Sep. 25, 1998

Safety studies support pediatric use of MKC-442

Sep. 24, 1998

Caelyx receives approval in Canada

Sep. 24, 1998

Isis Pharmaceuticals receives milestone payment from Ciba Vision for Vitravene

Sep. 24, 1998

Approved t.i.d. dosing regimen of Crixivan proves superior to b.i.d. regimen

Sep. 23, 1998

Trimeris initiates patient selection and dosing in phase II trial of T-20 in HIV patients

Sep. 23, 1998

Another treatment option added to the anti-HIV arsenal: efavirenz gets FDA approval

Sep. 21, 1998

Japan Energy presents new HIV protease inhibitors

Sep. 21, 1998

Canadian approval for Viramune announced

Sep. 18, 1998

Boston Biomedica's newest anti-HIV candidates receive patent protection in U.S.

Sep. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...